VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares Posted on October 13, 2022July 10, 2023 by fraziermwd
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock Posted on October 4, 2022July 10, 2023 by fraziermwd
Sudo Biosciences Raises $37M Series A Financing to Advance Precision TYK2 Therapeutics Posted on September 28, 2022July 10, 2023 by fraziermwd
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock Posted on September 19, 2022July 10, 2023 by fraziermwd
FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older Posted on July 29, 2022July 10, 2023 by fraziermwd
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners Posted on May 9, 2022July 10, 2023 by fraziermwd
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults Posted on May 3, 2022July 10, 2023 by fraziermwd
HilleVax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Posted on May 3, 2022July 10, 2023 by fraziermwd
